ABK Biomedical

About:

ABK Biomedical combines the clinical market with biomaterials with a focus on treating hypervascular tumors.

Website: http://www.abkbiomedical.com/

Top Investors: F-Prime Capital, Innovacorp, Eight Roads Ventures, Sante Ventures, Varian

Description:

ABK Biomedical combines the clinical market with biomaterials. It specializes in improving treatment options for patients with hypervascular tumors. The company is dedicated to transforming an interventional radiology procedure called embolization.

Total Funding Amount:

$67.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Halifax, Nova Scotia, Canada

Founded Date:

2012-01-01

Contact Email:

info(AT)abkbiomedical.com

Founders:

Bob Abraham, Daniel Boyd, Sharon Kehoe

Number of Employees:

11-50

Last Funding Date:

2022-12-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai